Aspire BioPharma Inc. (ASBP)
0.64
-0.05 (-7.00%)
At close: Mar 21, 2025, 3:56 PM
0.67
4.77%
After-hours: Mar 21, 2025, 06:50 PM EDT
-7.00% (1D)
| Bid | 0.61 |
| Market Cap | 29.33M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | n/a |
| EPS (ttm) | -0.01 |
| PE Ratio (ttm) | -63.75 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 0.78 |
| Volume | 426,918 |
| Avg. Volume (20D) | 435,538 |
| Open | 0.69 |
| Previous Close | 0.69 |
| Day's Range | 0.61 - 0.69 |
| 52-Week Range | 0.52 - 15.80 |
| Beta | 0.37 |
About ASBP
Aspire BioPharma, Inc. is a biotechnology company specializing in advanced diagnostic solutions and molecular testing. The company focuses on developing high-precision assays for disease detection, leveraging cutting-edge research in genetics and biochemistry to support healthcare and life sciences industries....
Industry Biotechnology
Sector Healthcare
IPO Date Apr 11, 2022
Employees 2
Stock Exchange NASDAQ
Ticker Symbol ASBP
Website https://aspirebiolabs.com/
